Benzenesulfonamide,N-[4-[(4aR,10bS)-1,2,3,4,4a,10b-hexahydro-8,9-dimethoxy-2-methylbenzo[c][1,6]naphthyridin-6-yl]phenyl]-4-methyl-,rel-(-)- (139308-65-9)

Identification
Name:	Benzenesulfonamide,N-[4-[(4aR,10bS)-1,2,3,4,4a,10b-hexahydro-8,9-dimethoxy-2-methylbenzo[c][1,6]naphthyridin-6-yl]phenyl]-4-methyl-,rel-(-)-
Synonyms:	Benzenesulfonamide,N-[4-(1,2,3,4,4a,10b-hexahydro-8,9-dimethoxy-2-methylbenzo[c][1,6]naphthyridin-6-yl)phenyl]-4-methyl-,cis-(-)-;(-)-4'-(cis-1,2,3,4,4a,10b-Hexahydro-8,9-dimethoxy-2-methylbenzo[c][1,6]naphthyridin-6-yl)-p-toluenesulfonanilide;Tolafentrine
CAS:	139308-65-9
Molecular Formula:	C28H31 N3 O4 S
Molecular Weight:	0
InChI:	InChI=1/C28H31N3O4S/c1-18-5-11-21(12-6-18)36(32,33)30-20-9-7-19(8-10-20)28-23-16-27(35-4)26(34-3)15-22(23)24-17-31(2)14-13-25(24)29-28/h5-12,15-16,24-25,30H,13-14,17H2,1-4H3/t24-,25-/m0/s1
Molecular Structure:
Properties
Flash Point:	331.6°C
Boiling Point:	624.7°C at 760 mmHg
Density:	1.29g/cm³
Refractive index:	1.64
Flash Point:	331.6°C
Usage:	A dual-selective phosphodiesterase 3/4 inhibitor used in chronic experimental pulmonary hypertension.
Safety Data